Lirimilast
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-19672-10 mg |
| CAS # | 329306-27-6 |
| Pricing | 10 mg, USD $950.0 |
| Synonyms | BAY 19-8004 |
| MWt | 443.26 |
| Formula | C₁₇H₁₂Cl₂N₂O₆S |
| Biological Activity | Lirimilast (BAY 19-8004) is a potent, selective and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 value of 49 nM. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease (COPD). Lirimilast has potently anti-inflammatory properties[1][2]. |
| Purity | ≥98.0% |